Apellis Pharmaceuticals to Present at the BMO 2020 Prescriptions for Success Healthcare Conference

Rhea-AI Summary

Apellis Pharmaceuticals (Nasdaq: APLS) announced its participation in the BMO 2020 Prescriptions for Success Healthcare Conference on June 23, 2020, at 11:30 a.m. ET. The event will be held virtually, featuring a fireside chat with Cedric Francois, M.D., Ph.D., co-founder and CEO. The presentation can be accessed via live webcast on the company’s website, with a replay available for 90 days. Apellis is focused on developing targeted C3 therapies for serious diseases affected by the complement cascade, including conditions in hematology, ophthalmology, and nephrology.

WALTHAM, Mass., June 16, 2020 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) a global biopharmaceutical company pioneering targeted C3 therapies, today announced that the company will present at the BMO 2020 Prescriptions for Success Healthcare Conference on Tuesday, June 23, 2020 at 11:30 a.m. ET. The conference will be held in a virtual meeting format.

Cedric Francois, M.D., Ph.D., co-founder and chief executive officer of Apellis, will participate in a fireside chat. The event will be available via live webcast from the “Events and Presentations” page of the “Investors and Media” section of the company’s website at https://investors.apellis.com/events-and-presentations. A replay of the webcast will be available for 90 days following the event.

About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. By pioneering targeted C3 therapies, we aim to develop best-in-class and first-in-class therapies for a broad range of debilitating diseases that are driven by uncontrolled or excessive activation of the complement cascade, including those within hematology, ophthalmology, and nephrology.

Investor Contact:
Sam Martin / Maghan Meyers
Argot Partners
sam@argotpartners.com / maghan@argotpartners.com
212.600.1902

FAQ

When is Apellis Pharmaceuticals presenting at the BMO Healthcare Conference?

Apellis Pharmaceuticals will present on June 23, 2020, at 11:30 a.m. ET.

Who will represent Apellis Pharmaceuticals at the BMO Healthcare Conference?

Cedric Francois, M.D., Ph.D., co-founder and CEO, will participate in the fireside chat.

How can I watch the Apellis Pharmaceuticals presentation at the BMO Conference?

The presentation will be available via live webcast on the Apellis website's 'Events and Presentations' page.

Is there a replay available of the Apellis Pharmaceuticals webcast?

Yes, a replay of the webcast will be available for 90 days after the event.

What is the focus of Apellis Pharmaceuticals' research?

Apellis focuses on developing targeted C3 therapies for diseases driven by the complement cascade.